Facebook Linkedin RSS Twitter Youtube
Home 2024

Caribou Biosciences

StockWatch: PacBio Scores Biggest One-Day Gain Since 2018, but Momentum Fades
GEN Edge

StockWatch: PacBio Scores Biggest One-Day Gain Since 2018, but Momentum Fades

StockWatch: Nvidia’s $3T Market Cap, Tempus’ $400M IPO Reflect AI Allure
Artificial Intelligence

StockWatch: Nvidia’s $3T Market Cap, Tempus’ $400M IPO Reflect AI Allure

Top 10 Publicly Owned Gene Editing Therapy Companies
A-Lists

Top 10 Publicly Owned Gene Editing Therapy Companies

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar
GEN Edge

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar

StockWatch: Caribou Shares Surge on $25M Pfizer Investment
GEN Edge

StockWatch: Caribou Shares Surge on $25M Pfizer Investment

Force of Nature: Caribou Biosciences Hits Clinical Runway with CRISPR-based Cancer Therapeutics
Cancer

Force of Nature: Caribou Biosciences Hits Clinical Runway with CRISPR-based Cancer Therapeutics

CRISPR’s Second Decade: Jennifer Doudna Looks Forward and Back
Genome Editing

CRISPR’s Second Decade: Jennifer Doudna Looks Forward and Back

IPO Raises $304M for Caribou, Developer of Gene-Edited Cell Therapies
Genome Editing

IPO Raises $304M for Caribou, Developer of Gene-Edited Cell Therapies

“GEN Edge Live”: Analyzing the Latest Milestones in Genome Editing
GEN Edge

“GEN Edge Live”: Analyzing the Latest Milestones in Genome Editing

Caribou Rides RNA Wave with $115M Series C Financing
Cancer

Caribou Rides RNA Wave with $115M Series C Financing

12Page 1 of 2
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.